Clinical Trial 54242

Maitland, FL 32751


Have You or Someone You Know Been Diagnosed with Alzheimer’s Disease?

Consider Participating in Athira’s Clinical Trials

The clinical trials of fosgonimeton (ATH-1017) are evaluating if a new investigational drug is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease. 
Fosgonimeton is designed to boost a repair and regenerative pathway for brain cells, promoting brain health and function.



You or someone you know may be eligible if you:
♦ Are between 55 and 85 years of age
♦ Have been diagnosed with Alzheimer’s disease
♦ Have a reliable support person or caregiver who is willing to participate in study visits, report on daily activities and oversee or help you with taking fosgonimeton
♦ Are not taking acetylcholinesterase inhibitors (cholinergics) or have not taken within the last 4 weeks prior to screening



Qualified Participants May Receive:

Study participation and study drug are free to all participants. You may receive a stipend to compensate for time and effort for study participation including meals, travel, etc. 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.